In particular, it was not possible to correct results for the use of oral antidiabetic agents with proven beneficial cardiovascular effects, such as sodium glucose transporter-2 inhibitors and glucagon-like peptide-1 agonists, which were very marginally used at the time of ETNA-AF initiation. Here, GCG is linked to atrial fibrillation.